Variant report
Variant | nsv976450 |
---|---|
Chromosome Location | chr11:23521519-23540267 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:23536080-23536324 | HepG2 | liver: | n/a | chr11:23536181-23536192 |
2 | CEBPB | chr11:23535734-23535834 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr11:23521483-23521565 | LNCaP | prostate: | n/a | n/a |
4 | E2F4 | chr11:23530650-23530905 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr11:23530616-23530935 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr11:23530602-23530947 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr11:23530645-23530935 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr11:23530495-23531041 | HUVEC | blood vessel: | n/a | n/a |
9 | GATA2 | chr11:23530479-23531168 | HUVEC | blood vessel: | n/a | n/a |
10 | GATA3 | chr11:23524375-23524494 | SH-SY5Y | brain: | n/a | n/a |
11 | JUND | chr11:23536052-23536242 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr11:23538585-23538736 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr11:23522902-23523023 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr11:23530636-23530980 | IMR90 | lung: | n/a | n/a |
15 | MAZ | chr11:23527614-23527664 | HepG2 | liver: | n/a | n/a |
16 | MAZ | chr11:23538392-23538573 | HepG2 | liver: | n/a | n/a |
17 | MXI1 | chr11:23531509-23531586 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr11:23529123-23529224 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr11:23530621-23530949 | U87 | brain: | n/a | n/a |
20 | POLR2A | chr11:23532145-23532188 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr11:23537104-23537134 | HUVEC | blood vessel: | n/a | n/a |
22 | POLR2A | chr11:23532820-23532918 | ProgFib | skin: | n/a | n/a |
23 | POLR2A | chr11:23527330-23527388 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr11:23530582-23530943 | U87 | brain: | n/a | n/a |
25 | STAT1 | chr11:23536777-23536806 | GM12878 | blood: | n/a | n/a |
26 | STAT3 | chr11:23534860-23535038 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | UBTF | chr11:23522607-23522646 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000240881 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551052877 | chr11:23524498-23524499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs17306622 | chr11:23524507-23524508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs16911433 | chr11:23524536-23524537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10741982 | chr11:23524554-23524555 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs77547282 | chr11:23524572-23524573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368574386 | chr11:23524635-23524636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193127984 | chr11:23524647-23524648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576962228 | chr11:23524696-23524697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575785464 | chr11:23524716-23524717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538102836 | chr11:23524721-23524722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554221031 | chr11:23524730-23524731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185176670 | chr11:23524741-23524742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112753494 | chr11:23524793-23524794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35541279 | chr11:23524805-23524806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372119099 | chr11:23524817-23524818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532787078 | chr11:23524824-23524825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553321643 | chr11:23524833-23524834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10500959 | chr11:23524897-23524898 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs562577273 | chr11:23524913-23524914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546034736 | chr11:23524924-23524925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72877149 | chr11:23524948-23524949 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs531514467 | chr11:23524956-23524957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542077468 | chr11:23524974-23524975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541695142 | chr11:23525011-23525012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561881776 | chr11:23525015-23525016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10734342 | chr11:23525032-23525033 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs547119968 | chr11:23525034-23525035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566832373 | chr11:23525066-23525067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532441239 | chr11:23525111-23525112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527865364 | chr11:23525118-23525119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549017087 | chr11:23525159-23525160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374776389 | chr11:23525210-23525211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs56171407 | chr11:23525212-23525213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs190055115 | chr11:23525215-23525216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111815409 | chr11:23525229-23525230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72547744 | chr11:23525278-23525279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10734343 | chr11:23525279-23525280 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs554707345 | chr11:23525280-23525281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs57283448 | chr11:23525311-23525312 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs181036624 | chr11:23525323-23525324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144092852 | chr11:23525331-23525332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185453202 | chr11:23525349-23525350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545512288 | chr11:23525350-23525351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564435961 | chr11:23525391-23525392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146472230 | chr11:23525421-23525422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576224659 | chr11:23525433-23525434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542131575 | chr11:23525446-23525447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538459352 | chr11:23525467-23525468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117610772 | chr11:23525469-23525470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556692798 | chr11:23525498-23525499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:23524400-23526000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr11:23524800-23526400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr11:23529200-23529600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr11:23530200-23531600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:23530600-23531400 | Enhancers | NH-A | brain |
6 | chr11:23531000-23531200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr11:23534400-23540800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr11:23538800-23539600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr11:23539000-23539600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr11:23539000-23540600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr11:23539600-23540800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |